Figure 3From: Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts Cell cycle effects in vivo. Representative single parameter DNA histograms showed cell cycle effects following chronic dose administration of 3 orthotopic primary pancreatic cancer xenografts. Percent cells in G1, S and G2/M phases are given. For OCIP23, which is aneuploid, the values are for the cancer cells.Back to article page